Use of Biodegradable Temporising Matrix (BTM) in the reconstruction of diabetic foot wounds: A pilot study.

Scars, burns & healing Pub Date : 2022-09-21 eCollection Date: 2022-01-01 DOI:10.1177/20595131221122272
Beatrice Kuang, Guilherme Pena, Prue Cowled, Robert Fitridge, John Greenwood, Marcus Wagstaff, Joseph Dawson
{"title":"Use of Biodegradable Temporising Matrix (BTM) in the reconstruction of diabetic foot wounds: A pilot study.","authors":"Beatrice Kuang,&nbsp;Guilherme Pena,&nbsp;Prue Cowled,&nbsp;Robert Fitridge,&nbsp;John Greenwood,&nbsp;Marcus Wagstaff,&nbsp;Joseph Dawson","doi":"10.1177/20595131221122272","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Complex diabetes-related foot wounds are at high risk of infection and subsequent major amputation unless healed expediently. Biodegradable Temporising Matrix (BTM) is a synthetic matrix that facilitates the organisation of the extracellular matrix, resulting in a neodermis layer over these difficult-to-heal areas. The aim of this study was to evaluate the efficacy of using BTM in the reconstruction of challenging diabetic foot wounds.</p><p><strong>Methods: </strong>Eighteen patients with complex diabetic foot wounds (exposed tendon, fascia, joint, bone), or chronic ulcers at high shear stress locations had BTM applied. Indications for BTM application were high shear stress location (66.6%), exposed bone (16.6%), exposed fascia (5.6%), exposed tendon (5.6%) and chronic non-healing wound (5.6%). The time to complete healing, infection rate and incidence of subsequent wound breakdown was analysed.</p><p><strong>Discussion: </strong>Thirteen of 18 patients completed the BTM treatment regime with all these patients achieving complete wound healing at a median time of 13 weeks. One patient had partial treatment with BTM and four patients were withdrawn from the study following BTM application. The rate of infection and re-ulceration were both 15.4%.</p><p><strong>Conclusion: </strong>This is the first prospective cohort pilot study evaluating the use of BTM for complex diabetic foot wounds. BTM demonstrates potential in healing uninfected, non-ischaemic diabetic foot wounds with exposed deep structures and chronic wounds subject to high shear stress. The re-ulceration and infection rates were relatively low for this high-risk population. BTM may also offer promise as an alternative to free flaps.</p><p><strong>Lay summary: </strong>The prevalence of diabetes and its complications, including foot ulcers and wounds, have significantly increased worldwide over the last 40 years. Increasingly patients are admitted to hospital for antibiotics, debridements and subsequent amputations from these wounds. Complex diabetes-associated wounds are those at highest risk of these complications or necessitating more extensive, complex operations such as free flaps. These wounds may have exposed deep structures, be at risk of high shear stress or be chronic non-healing wounds.Temporisers are a type of material which integrates into the wound and promotes in-growth of tissue, ideal for healing over these difficult to heal areas. Biodegradable Temporising Matrix (BTM) is a synthetic temporising matrix which has demonstrated positive outcomes in facilitating healing in burns and plastics wounds, but its effectiveness in diabetic foot wounds has not yet been proven. This is the first prospective cohort pilot study evaluating the use of BTM for complex diabetic foot wounds. BTM demonstrates potential in healing uninfected, non-ischaemic complex diabetic foot wounds and potentially avoiding more complex operations.</p>","PeriodicalId":21495,"journal":{"name":"Scars, burns & healing","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e3/61/10.1177_20595131221122272.PMC9500262.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scars, burns & healing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20595131221122272","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: Complex diabetes-related foot wounds are at high risk of infection and subsequent major amputation unless healed expediently. Biodegradable Temporising Matrix (BTM) is a synthetic matrix that facilitates the organisation of the extracellular matrix, resulting in a neodermis layer over these difficult-to-heal areas. The aim of this study was to evaluate the efficacy of using BTM in the reconstruction of challenging diabetic foot wounds.

Methods: Eighteen patients with complex diabetic foot wounds (exposed tendon, fascia, joint, bone), or chronic ulcers at high shear stress locations had BTM applied. Indications for BTM application were high shear stress location (66.6%), exposed bone (16.6%), exposed fascia (5.6%), exposed tendon (5.6%) and chronic non-healing wound (5.6%). The time to complete healing, infection rate and incidence of subsequent wound breakdown was analysed.

Discussion: Thirteen of 18 patients completed the BTM treatment regime with all these patients achieving complete wound healing at a median time of 13 weeks. One patient had partial treatment with BTM and four patients were withdrawn from the study following BTM application. The rate of infection and re-ulceration were both 15.4%.

Conclusion: This is the first prospective cohort pilot study evaluating the use of BTM for complex diabetic foot wounds. BTM demonstrates potential in healing uninfected, non-ischaemic diabetic foot wounds with exposed deep structures and chronic wounds subject to high shear stress. The re-ulceration and infection rates were relatively low for this high-risk population. BTM may also offer promise as an alternative to free flaps.

Lay summary: The prevalence of diabetes and its complications, including foot ulcers and wounds, have significantly increased worldwide over the last 40 years. Increasingly patients are admitted to hospital for antibiotics, debridements and subsequent amputations from these wounds. Complex diabetes-associated wounds are those at highest risk of these complications or necessitating more extensive, complex operations such as free flaps. These wounds may have exposed deep structures, be at risk of high shear stress or be chronic non-healing wounds.Temporisers are a type of material which integrates into the wound and promotes in-growth of tissue, ideal for healing over these difficult to heal areas. Biodegradable Temporising Matrix (BTM) is a synthetic temporising matrix which has demonstrated positive outcomes in facilitating healing in burns and plastics wounds, but its effectiveness in diabetic foot wounds has not yet been proven. This is the first prospective cohort pilot study evaluating the use of BTM for complex diabetic foot wounds. BTM demonstrates potential in healing uninfected, non-ischaemic complex diabetic foot wounds and potentially avoiding more complex operations.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
生物可降解时间基质(BTM)在糖尿病足创伤重建中的应用:一项初步研究。
导言:复杂的糖尿病相关足部伤口感染和随后截肢的风险很高,除非及时愈合。可生物降解的临时基质(BTM)是一种合成基质,促进细胞外基质的组织,在这些难以愈合的区域上形成新真皮层。本研究的目的是评估BTM在糖尿病足创伤重建中的疗效。方法:18例复杂的糖尿病足创伤(暴露的肌腱、筋膜、关节、骨)或慢性溃疡在高剪切应力位置应用BTM。BTM应用适应症为高剪应力部位(66.6%)、骨外露(16.6%)、筋膜外露(5.6%)、肌腱外露(5.6%)和慢性未愈合伤口(5.6%)。分析两组患者愈合时间、感染率及创面破裂发生率。讨论:18例患者中有13例完成了BTM治疗方案,所有这些患者在13周的中位时间内实现了伤口完全愈合。1例患者接受BTM部分治疗,4例患者在应用BTM后退出研究。感染和再溃疡发生率均为15.4%。结论:这是首个评估BTM治疗复杂糖尿病足部伤口的前瞻性队列试验研究。BTM显示出愈合未感染、非缺血性糖尿病足部深部结构暴露伤口和高剪切应力慢性伤口的潜力。这些高危人群的再溃疡和感染率相对较低。BTM也有可能成为免费襟翼的替代品。摘要:在过去的40年里,糖尿病及其并发症,包括足部溃疡和伤口的患病率在世界范围内显著增加。越来越多的患者入院接受抗生素治疗、清创和随后的截肢手术。复杂的糖尿病相关伤口是那些并发症风险最高的伤口,或需要更广泛、更复杂的手术,如游离皮瓣。这些伤口可能有暴露的深层结构,有高剪切应力的风险,或者是慢性不愈合的伤口。暂时性创可贴是一种整合到伤口中并促进组织生长的材料,非常适合愈合这些难以愈合的区域。生物降解缓释基质(BTM)是一种合成缓释基质,在促进烧伤和塑料伤口愈合方面表现出积极的效果,但其在糖尿病足部伤口中的有效性尚未得到证实。这是第一个评估BTM治疗复杂糖尿病足部伤口的前瞻性队列试验研究。BTM显示了治疗未感染、非缺血性复杂糖尿病足伤口的潜力,并有可能避免更复杂的手术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Effect of oral Calendula officinalis on second-degree burn wound healing. To bleed or not to bleed? Case series and discussion of haemorrhage risk with enzymatic debridement in burn injuries. An evaluation of clinical psychology input into burns multidisciplinary follow-up clinics. The efficacy of combined ultrasound and electric field stimulation therapy in the treatment of venous leg ulcers. Protocol for clinical diagnosis and empiric treatment of pulmonary tuberculosis in severely burned patients: observations and literature review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1